CytomX Therapeutics, Inc. (CTMX)
USD 1.06
(-6.19%)
USD 1.06
(-6.19%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -56.03 Million | -110.78 Million | -119.03 Million | 5.25 Million | -140.48 Million | -75.52 Million |
| Net Income | -569 Thousand | -99.31 Million | -83.6 Million | -32.88 Million | -102.23 Million | -84.6 Million |
| Depreciation & Amortization | 2.17 Million | 2.44 Million | 2.7 Million | 2.57 Million | 2.6 Million | 1.88 Million |
| Deferred income taxes | -31.12 Million | - | 272 Thousand | -236 Thousand | -2.22 Million | - |
| Stock-based compensation | 8.55 Million | 13.12 Million | 13.16 Million | 14.78 Million | 19.1 Million | 16.87 Million |
| Change in working capital | -62.5 Million | -30.65 Million | -54.7 Million | 18.13 Million | -59.32 Million | -7.97 Million |
| Other non-cash items | 27.43 Million | 3.61 Million | 3.13 Million | 2.88 Million | 1.6 Million | -1.7 Million |
| Investing Cash Flow | -150.67 Million | 98.26 Million | 22.48 Million | -18.71 Million | 79.7 Million | 5.92 Million |
| Investments in PPE | -840 Thousand | -1.74 Million | -1.6 Million | -2.3 Million | -3.49 Million | -3.78 Million |
| Acquisitions | 149.83 Million | - | -24.09 Million | 16.4 Million | -83.19 Million | -5.92 Million |
| Investment purchases | -424.83 Million | - | -99.89 Million | -199.1 Million | -174.99 Million | -204.6 Million |
| Sales/Maturities of investments | 275 Million | 100 Million | 123.99 Million | 182.69 Million | 258.19 Million | 214.31 Million |
| Other Investing Activities | -149.83 Million | 100 Million | 24.09 Million | -16.4 Million | 83.19 Million | 5.92 Million |
| Financing Cash Flow | 30.23 Million | 648 Thousand | 110.21 Million | 16.89 Million | 1.62 Million | 139.62 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 30.23 Million | 648 Thousand | 107.71 Million | 11.28 Million | 1.6 Million | 134.59 Million |
| Other Financing Activities | 30.23 Million | 648 Thousand | 2.5 Million | 5.6 Million | 25 Thousand | 5.02 Million |
| Accounts receivables | 32.55 Million | -35.19 Million | 8000.00 | -785 Thousand | 84 Thousand | 10.04 Million |
| Accounts payables | -1.42 Million | 68 Thousand | -139 Thousand | -857 Thousand | -374 Thousand | 261 Thousand |
| Inventory | - | - | 11.64 Million | -11.11 Million | -11.29 Million | 19.91 Million |
| Other working capital | -93.63 Million | 4.47 Million | -66.2 Million | 30.89 Million | -47.74 Million | -38.19 Million |
| Cash at beginning of period | 193.65 Million | 206.44 Million | 192.77 Million | 189.34 Million | 248.49 Million | 178.46 Million |
| Cash at end of period | 17.17 Million | 194.56 Million | 206.44 Million | 192.77 Million | 189.34 Million | 248.49 Million |
| Capital Expenditure | -840 Thousand | -1.74 Million | -1.6 Million | -2.3 Million | -3.49 Million | -3.78 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -176.47 Million | -11.88 Million | 13.67 Million | 3.43 Million | -59.15 Million | 70.02 Million |
| Free Cash Flow | -56.87 Million | -112.52 Million | -120.64 Million | 2.95 Million | -143.97 Million | -79.3 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -6.53 Million | 13.79 Million | 837 Thousand | -569 Thousand | 2.99 Million | -1.08 Million |
| Depreciation & Amortization | 459 Thousand | 467 Thousand | 486 Thousand | 2.17 Million | 484 Thousand | 610 Thousand |
| Deferred income taxes | - | - | -4.86 Million | -31.12 Million | -1.93 Million | -1.72 Million |
| Stock-based compensation | 1.88 Million | 1.9 Million | 2.55 Million | 8.55 Million | 1.22 Million | 2.37 Million |
| Change in working capital | -14.92 Million | -41.33 Million | -24.57 Million | -62.5 Million | -21.95 Million | -26.26 Million |
| Other non-cash items | -6.6 Million | 11.12 Million | 3.6 Million | 27.43 Million | 942 Thousand | 922 Thousand |
| Investing Cash Flow | 21.51 Million | 44.88 Million | 12.86 Million | -150.67 Million | -42.93 Million | 26.04 Million |
| Investments in PPE | -96 Thousand | -115 Thousand | -266 Thousand | -840 Thousand | -9000.00 | -517 Thousand |
| Acquisitions | - | - | -13.13 Million | 149.83 Million | 42.92 Million | -100 Million |
| Investment purchases | -93.39 Million | - | -111.86 Million | -424.83 Million | -92.92 Million | -73.44 Million |
| Sales/Maturities of investments | 115 Million | 45 Million | 125 Million | 275 Million | 50 Million | 100 Million |
| Other Investing Activities | - | 45 Million | 13.13 Million | -149.83 Million | -42.92 Million | 100 Million |
| Financing Cash Flow | 5.09 Million | 174 Thousand | 244 Thousand | 30.23 Million | 29.66 Million | 317 Thousand |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 5.09 Million | 174 Thousand | 244 Thousand | 30.23 Million | 29.66 Million | 317 Thousand |
| Other Financing Activities | 5.09 Million | 174 Thousand | 244 Thousand | 30.23 Million | 29.66 Million | 317 Thousand |
| Accounts receivables | 10.4 Million | -9.74 Million | -1.01 Million | 32.55 Million | -516 Thousand | -813 Thousand |
| Accounts payables | -1.42 Million | 581 Thousand | -328 Thousand | -1.42 Million | 676 Thousand | -1.15 Million |
| Inventory | - | - | -1.00 | - | 2.38 Million | -1.53 Million |
| Other working capital | -23.9 Million | -32.16 Million | -23.23 Million | -93.63 Million | -24.49 Million | -22.76 Million |
| Cash at beginning of period | 36.18 Million | 17.17 Million | 26.02 Million | 193.65 Million | 58.45 Million | 57.27 Million |
| Cash at end of period | 43.24 Million | 36.18 Million | 17.17 Million | 17.17 Million | 26.94 Million | 58.45 Million |
| Capital Expenditure | -96 Thousand | -115 Thousand | -266 Thousand | -840 Thousand | -9000.00 | -517 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 7.06 Million | 19.01 Million | -8.85 Million | -176.47 Million | -31.51 Million | 1.17 Million |
| Free Cash Flow | -19.64 Million | -26.16 Million | -22.22 Million | -56.87 Million | -18.25 Million | -25.69 Million |
OMV
GRPOF
TORO
KALYANIFRG
5657
IDYA